key: cord-0902807-8qc9q7rp
authors: Fang, Cong; Bai, Song; Chen, Qianlan; Zhou, Yu; Xia, Liming; Qin, Lixin; Gong, Shi; Xie, Xudong; Zhou, Chunhua; Tu, Dandan; Zhang, Changzheng; Liu, Xiaowu; Chen, Weiwei; Bai, Xiang; Torr, Philip H.S.
title: Deep learning for predicting COVID-19 malignant progression
date: 2021-05-12
journal: Med Image Anal
DOI: 10.1016/j.media.2021.102096
sha: 03d8f5e4a02323d7cfb7ec30648c34dfda9951fa
doc_id: 902807
cord_uid: 8qc9q7rp

As COVID-19 is highly infectious, many patients can simultaneously flood into hospitals for diagnosis and treatment, which has greatly challenged public medical systems. Treatment priority is often determined by the symptom severity based on first assessment. However, clinical observation suggests that some patients with mild symptoms may quickly deteriorate. Hence, it is crucial to identify patient early deterioration to optimize treatment strategy. To this end, we develop an early-warning system with deep learning techniques to predict COVID-19 malignant progression. Our method leverages CT scans and the clinical data of outpatients and achieves an AUC of 0.920 in the single-center study. We also propose a domain adaptation approach to improve the generalization of our model and achieve an average AUC of 0.874 in the multicenter study. Moreover, our model automatically identifies crucial indicators that contribute to the malignant progression, including Troponin, Brain natriuretic peptide, White cell count, Aspartate aminotransferase, Creatinine, and Hypersensitive C-reactive protein.

Since 2020, COVID-19 has had a fundamental effect on peoples lives. As of August 12, 2020, the number of COVID-19 infections in the world has soared to 20.2 million (20, 162, 474 ) with a mortality of 3.7% (737,417/20,162,474) (Organization et al., 2020) , which greatly challenges public medical systems. France and The United Kingdom have the highest mortality in the world, which is 15.8% 5 (30,227/191,265) and 14.9% (46,526/312,793) , respectively. In comparison, the mortality in some other countries is much lower, such as 4. 2% (9,207/218,519) in Germany (Organization et al., 2020) . One of the most important causes for such a difference in mortalities is early identification and active intervention of patients with mild symptoms to prevent deterioration (Bennhold, 2020) .

Clinical observations (Cummings et al., 2020; Wu and McGoogan, 2020) suggest that although 10 around 80% of COVID-19 patients are mild or asymptomatic, some of them may rapidly deteriorate.

More importantly, studies have shown that over 60% of patients died once they progressed into a severe/critical stage. Thus this group of patients requires special attention and treatment in advance. Therefore, the focus of this study, as illustrated in Figure 1 , is on an accurate prediction of COVID-19 malignant progression, which is conducive to the timely intervention of 15 clinicians, rational optimization of medical resources, and the effective operation of the entire medical system.

Current research mainly focuses on exploiting clinical variables ascertained at hospital admission or quantitative CT parameters for progression prediction via multivariate regression (Gong et al., 2020; Ji et al., 2020) , Light Gradient Boosting Machine (LightGBM) (Zhang et al., 2020c), or 20 Least Absolute Shrinkage and Selection Operator (LASSO) (Liang et al., 2020a) . However, the performance of those methods is still far from that required for practical use, for three reasons: 1) a manual quantization of feature patterns is required, which leads to information loss before analysis;

2) temporal cues are more or less ignored, but crucial to an accurate prediction; 3) chest Computed Tomography (CT) scans and the clinical data capture different characteristics of patients, but the 25 complementarity between them is not fully leveraged.

To address the above issues, we resort to Artificial Intelligence (AI) techniques to deliver an accurate model for predicting COVID-19 malignant progression. Based on deep learning methods (He et al., 2016; Hochreiter and Schmidhuber, 1997; Hornik et al., 1989) , our model effectively mines the complementary information in the static clinical data and the dynamic sequence of chest 30 CT scans. It operates on raw data in an end-to-end manner, which means any manual design of feature patterns or interference of clinicians is not required. Moreover, our model automatically identifies crucial indicators that contribute to the malignant progression, including Troponin, Brain natriuretic peptide, White cell count, Aspartate aminotransferase, Creatinine, and Hypersensitive C-reactive protein.

In summary, our work presents an early warning system and targets early identification of 

In this section, we first provide a short review of previous studies on the COVID-19 diagnosis and prognosis, then introduce temporal information exploring and domain adaptation on medical images.

In the past few months, AI-based methods have played an important role in this epidemic. In outbreak areas, COVID-19 patients are in urgent need of diagnosis. Due to fast acquisition, some works perform X-ray (Wong et al., 2019; Sitaula and Hossain, 2020; Minaee et al., 2020) and CT scans (Di et al., 2020; Yang et al., 2021; Gao et al., 2020a) to identify COVID-19. Besides early screening, the study of malignant progression prediction is also important for treatment planning. Demographic 55 and clinical characteristics (Liang et al., 2020a,b; Ji et al., 2020) are the most commonly used input of the prediction model. Simultaneously, quantitative CT features (Zhang et al., 2020b ) obtained by radiographic knowledge or deep learning-based method are the alternative input information.

Besides, segmentation as the essential step in COVID-19 quantification and diagnosis has been extensively studied. Gao et al. (2020a) develop a dual-branch combination network for COVID-60 19 diagnosis that can simultaneously achieve individual-level classification and lesion segmentation. Fan et al. (2020) propose a parallel partial decoder with a reverse attention module to model the boundaries and enhance the representations for the semi-supervised framework. Wang et al. (2020) introduce a noise-robust Dice loss with an adaptive self-ensembling framework to learn from noisy labels for the segmentation of COVID-19 Pneumonia Lesions.

The Long Short-Term Memory (LSTM) network is the most commonly used sequential information modeling method on medical imaging. Liang et al. (2018) (TS-SVM) model to constrain the partial MR image sequences detection score to increase monotonically with AD progression.

Domain adaptation is a popular learning scenario in medical imaging, referred to as the different domain, same task scenario. In the domain adaptation, we are dealing with, for example, data is to align the source and target domains by the feature space transformation (Conjeti et al., 2016; Guerrero et al., 2014; Hofer et al., 2017) . In this work, we use a metric-based method to bridge the domain gap between different data centers by a few labeled samples. 

In Wuhan Pulmonary Hospital, data from 199 patients were collected from January 3, 2020, to February 13, 2020. In Tongji Hospital, data from 2,543 patients were collected from January 13, 2020, to March 16, 2020, of which 544 patients came from the Zhongfa branch, 363 patients came from the Guanggu branch, and 71 patients came from the Main branch. All patients were confirmed 95 by a positive viral nucleic acid test. A subset of 1,040 adult patients belonging to the mild type at admission assessments is selected for further investigation. The inclusion criteria are all of the followings: 1) respiratory rate < 30 breaths per min; 2) resting blood oxygen saturation > 93%; 3) the ratio of arterial oxygen partial pressure to fraction of inspiration oxygen > 300 mm Hg; 4) non-ICU patients without shock, respiratory failure, mechanical ventilation, and failure of other organs.

Anyone who fails to fulfill one of the criteria is considered to progress into a severe/critical stage according to the guidelines for the COVID-19 infection diagnosis and treatment by the National Health Commission of the Peoples Republic of China (Version 7). The medical history, physical examination results, and laboratory tests were all collected from the HIS system. The time points of symptoms onset and the beginning of severe/critical stage are recorded for further selections of 105 available CT scans. All the patients in the Main branch have mild prognoses, so our research excludes patients from this branch. Furthermore, considering the age imbalance problem, we exclude patients under 18 years old. We finally obtain 61 clinical indicators for each sample. Figure 2 illustrates the flowchart of patient selection.

All the patients underwent serial pulmonary CT exams on dedicated CT scanners (GE, SIEMENS, TOSHIBA, and UNITED IMAGING) in two hospitals with the following parameters: slice thickness 1-3 mm, slice gap 0 mm, 130 kV, 50 mAs. All CT scans before the severe/critical stage are included to segment the masks of bilateral lungs and pneumonia on an autonomous system (HUAWEI CLOUD Launches AI-Assisted Diagnosis Platform for COVID-19). Each CT scan is downsampled to a width As traditional machine learning methods cannot handle raw CT scans directly, we design a set of hand-crafted quantitative features for experimental comparison. These quantitative features include 120 the infection pixels proportion and the average CT value of infection pixels for each CT slice. Finally, a 128-dimensional vector can be obtained for each CT scan. We use zero-padding for the missing CT scan tensor. To model the temporal information across the sequence of CT features, we use LSTM for its high 130 capacity in modeling such information (Shi et al., 2017) and densely combine the clinical feature and the CT feature via concatenation at each time step. LSTM employed in this study is a singlelayer network with an embedding dimension of 189 and a hidden dimension of 378. The output of LSTM, a 378 × 7 tensor, is flattened and then fed into several fully connected layers. Finally, we normalize the output with a softmax layer, which can be interpreted as the probability of the 135 patient's conversion to the severe/critical stage. The whole model is trained with the cross-entropy loss. The detailed architecture of our model is given in Supplementary Table 1 .

In domain adaptation, we use a metric-based method by using a few labeled samples to bridge the domain gap between the source center (cohort one) and the target center (cohort three). Figure   140 4 illustrates the proposed domain adaptation process. Specifically, our method can be decomposed into two stages: a pre-training stage and a domain adaptation stage. For the pre-training stage, we first train a model on the source center then remove the classifier to get the pre-trained encoder f φ .

For the domain adaptation stage, which is the core of our method, we adapt the pre-trained model through a metric-based approach, passing the prototype representations learned from the source 145 center to the target center. The details of this stage are elaborated as follows.

First, we randomly select N labeled samples from each class in the target center as the supportset to compute prototypes. Simultaneously, we randomly choose one sample per class in the target center as the query-set to compute distances to the prototypes in the embedding space. Specifically, in each class let S = {(x 1 , y 1 ), , (x N , y N )} denotes a small support-set of N labeled samples, where 150 x i is the feature vector of an example and y i ∈ {0, 1} is the corresponding label. S k denotes the support-set of examples with class k ∈ {0, 1}. We compute the mean vector w k of the embedded support points as prototypes for the two classes:

Second, we compute the predicted probability distribution for each sample in the query-set based on a softmax over its cosine similarities (denoted by sim(.)) with the prototypes in the embedding 155 space:

Similar to the studies of Gidaris and Komodakis (2018) Finally, we train our framework with the classification and similarity losses jointly. Concretely, 160 the classification loss is computed based on p and the labels in the query-set:

where L CE is the cross-entropy loss. The similarity loss is adopted to increase the distance between the two class prototypes, which is defined as:

Based on the above two losses, our final loss function is formulated as:

where γ is the coefficient to balance the two loss terms.

In the testing stage, all labeled samples in the support-set and the query-set are used to compute prototypes. A test sample will be classified by the similarity between the feature vector of the sample and the prototype of class k.

The proposed network is implemented using Python (Version 3.6 with scipy, scikit-learn, and 170 PyTorch). For single-center experiments on the cohort one, the network is trained by Adam optimizer with an initial learning rate of 0.05, and a batch size of 32 on a single NVIDIA Titan X GPU. The learning rate is decayed by a factor of 10 every 30 epochs. We train our model for 100 epochs. Model weights are initialized with the Kaiming method (He et al., 2015) , and biases are initialized as 0.

For multicenter experiments on the cohort three, we use the same optimizer settings as single-center experiments but with a fixed learning rate of 0.01. We finetune 50 epochs for domain adaptation, and the batch size is the same as the number of labeled samples with a maximum of 20. The cosine scaling parameter τ is initialized to 5 with a fixed learning rate of 0.1. The loss coefficient λ is 0.5.

The margin of the similarity loss is set to 0.2.

The AUC, accuracy, sensitivity, specificity, and Receiver Operating Characteristic Curve (ROC) are used to evaluate the model performance. The calculation method is shown in Supplementary methods. The 95% bilateral confidence interval is used for all metrics, where the AUC metric uses the Wald-cc interval (Kottas et al., 2014; Delong et al., 1988) we do not quantify CT scans to avoid information loss but use a deep learning model to process the raw data directly. In the meantime, effective integration of CT scans and clinical information 200 underpins our system.

In Table 2 , we compare the performance of our model against different methods, including Linear Discriminant Analysis (LDA) (Fisher, 1936) , Support Vector Machine (SVM) (Cortes and Vapnik, 1995) , and MLP (Hornik et al., 1989) . In this experiment, we adopt patients with mild symptoms and without malignant progression as the negative reference standard and divide the cohort one into the 205 training cohort (80%) and the validation cohort (20%) randomly. We use five-fold cross-validation to evaluate our model. Our system, which fuses sequential CT scans with the clinical information, According to the results in Table 2 , we can draw the following conclusions: 1) CT scans turns 210 out to be more effective than quantitative CT features. For instance, with LSTM, using CT scans obtain a relative improvement of 2.3% over using quantitative CT features in AUC (0.920 vs. 0.899).

Without LSTM, the improvement is more distinctive, reaching 8.1% (0.851 vs. 0.787). 2) Modeling the temporal information brings measurable benefits for boosting the performance of our system. 

In this study, there are two types of feature selection algorithms for clinical data, i.e., LASSO (Tibshirani, 1996) 

A high-quality labeling process typically requires time-consuming human effort, which is a prominent drawback during the outbreak of COVID-19, where fast analysis is essential. Hence, how to use a small amount of labeled data to improve the generalization power of the system is of great practical significance. Inspired by metric learning-based methods (Snell et al., 2017) , we propose a domain adaptation method to adapt our model to a new domain with only a few labeled samples 245 available. The details are given in the Methods section.

As Table 4 

Coronavirus-induced pneumonia puts tremendous pressure on public medical systems. Such patients without timely and effective treatment will eventually develop multi-organ failure associated with high mortality Wu and McGoogan, 2020) . Therefore, early prediction and early aggressive treatment of patients with mild symptoms at a high risk of malignant progression 270 to a severe/critical stage are important ways to reduce mortality. In this study, we argue that the effective integration of sequential CT scans and the clinical data is important for an accurate prediction of malignant progression. Moreover, the rich temporal information in the sequence of CT scans, which has not been considered by any studies so far, is critical for this specific task. We have conducted extensive experiments to demonstrate that our 275 system, which effectively fuses the two complementary data, achieves much better performance than using either data as input separately (e.g., 0.851 vs. 0.787 in AUC when using the clinical data and quantitative CT features). More importantly, due to the capability of our system in learning temporal information, our system reports a much higher AUC compared with the counterparts that do not consider the temporal information.

Our work is novel because we are among the first attempts to explore ways to fuse sequential CT scans and the clinical data to improve COVID-19 malignant progression predicting in an end-to-end Traditional machine learning methods heavily rely on domain-specific expertise. Feature patterns to be analyzed are manually designed, leading to information loss before feeding them to the classifier.

However, our method attempts to automatically learn complementary and temporal features from raw data and jointly optimizes the feature extractor and classifier in an end-to-end manner.

Deep learning-based methods often encounter performance degradation in the multicenter study, mainly due to the large data distribution discrepancy between different cohorts. This is caused by different CT scanners, different slice thickness, different regions, age distribution discrepancy, and systematic errors during the data collection process. Another notable merit of this work is that we employ domain adaptation to improve the robustness of our system in the multicenter 295 study. From comprehensive experimental results, we observe that inferior performance is achieved when the model trained with a single-center is adapted to a completely different data domain by directly fine-tuning. The proposed domain adaptation process enables our system to transfer the prototype representations learned from the source domain to the target domain with a small number of labeled samples, which greatly improves the generalization power in the multicenter evaluation. A 300 well-trained and mature prediction system in one center, which can be quickly deployed in multiple centers, will greatly reduce the significant demand for diagnostic expertise. It effectively optimizes the treatment strategy, thus improving the emergency response capacity of the medical system.

To investigate the interpretability of the CT feature patterns learned by our model, we show the activation maps via using Gradient-weighted Class Activation Mapping (Grad-CAM) (Selvaraju 305 et al., 2017) . Figure 10 shows that the intra-zone and middle-zone of the pulmonary region have the greatest influence on the prediction task. Hence, they are valuable for malignant progression prediction.

Our model could effectively identify valuable indicators for predicting the malignant progression of COVID-19 patients with mild symptoms, which assists in clinical assessment and treatment. According to our results, dysfunction or injuries of multiple organs are essential predictive indicators for COVID-19 malignant progression, of which myocardial injury is the most important one, followed by liver dysfunction and kidney failure. Coronavirus is currently believed to invade host cells through the Angiotensin-Converting Enzyme 2 (ACE2) pathway to cause COVID-19 (Lan et al., 2020; Zheng et al., 2020; Sama et al., 2020; Devaux et al., 2020; Bourgonje et al., 2020; Alqahtani 315 and Schattenberg, 2020). Since ACE2 is widely distributed in various human tissues, such as type II alveolar cells, myocardial cells, hepatocytes, cholangiocytes, and proximal tubule cells, multiple organ involvement in COVID-19 is not surprising (Alqahtani and Schattenberg, 2020; Zheng et al., 2020; Zhang et al., 2020a) . The inflammatory storm caused by coronavirus is another essential predictive indicator for COVID-19 malignant progression. Although the exact mechanisms are un- Second, the data source of our study is limited to three hospital branches of two hospitals in Wuhan.

More data needs to be collected from multiple centers, especially from foreign hospitals, to further enhance our model. Third, this study only conducts an interpretable analysis of the relationship between prognostic factors and patients who are easy to deteriorate from the perspective of relevance.

Future studies can combine evidence-based medicine to identify the cause and effect of malignant 335 progression.

In conclusion, our early warning system, built upon the deep learning techniques and the integration of sequential CT scans and the clinical data, can accurately predict the malignant progression of COVID-19. Compared with traditional machine learning methods, we demonstrate that our 340 deep learning-based method can learn discriminative feature patterns and improve the prediction performance significantly. Furthermore, the generalization power of our method is improved by domain adaptation in the multicenter study. Our method can identify patients with potentially severe/critical COVID-19 outcomes using an inexpensive, widely available point-of-care test. Our system can be potentially deployed on the front line to decrease the mortality of COVID-19.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 

The code and the pre-trained models are available on GitHub: https://github.com/CongFang/PMP-

365

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

nflict of Interest Form

Liver injury in covid-19: The current evidence

A german exception? why the countrys coronavirus death rate is low

Scalable unsupervised domain adaptation for electron microscopy

Angiotensin-converting enzyme-2 (ace2), sars-cov-2 and pathophysiology of coronavirus disease 2019 (covid-19)

Interval estimation for a binomial proportion

Transfer learning for multicenter classification of chronic obstructive pulmonary disease

Supervised domain adaptation of decision forests: Transfer of models trained in vitro for in vivo intravascular ultrasound tissue characterization

Support-vector networks

Epidemiology, clinical course, and outcomes of critically ill adults with covid-19 in new york city: a prospective cohort study

Comparing the areas under two or more 390 correlated receiver operating characteristic curves: a nonparametric approach

Ace2 receptor polymorphism: Susceptibility to sarscov-2, hypertension, multi-organ failure, and covid-19 disease outcome

Hypergraph learning for identification of covid-19 with ct imaging

Approximate statistical tests for comparing supervised classification learning algorithms

Inf-net: Automatic covid-19 lung infection segmentation from ct images

The use of multiple measurements in taxonomic problems

Dual-branch combination network (dcn): Towards accurate diagnosis and lesion segmentation of covid-19 using ct images

Time-distanced gates in long short-term memory 410 networks

Dynamic few-shot visual learning without forgetting

IEEE/CVF Conference on Computer Vision and Pattern Recognition

A tool to early predict severe corona virus disease 2019 (covid-19): a multicenter study 415 using the risk nomogram in wuhan and guangdong, china

Dalsa: Domain adaptation for supervised learning from sparsely annotated mr images

Manifold alignment and transfer learning for classifica-420 tion of alzheimer's disease

Delving deep into rectifiers: Surpassing human-level performance on imagenet classification

Deep residual learning for image recognition

Long short-term memory

Simple domain adaptation for crossdataset analyses of brain mri data

Multilayer feedforward networks are universal approximators

Prediction for progression risk in patients with covid-19 pneumonia: the call score

A modified wald interval for the area under the roc curve (auc) in diagnostic case-control studies

Structure of the sars-cov-2 spike receptor-binding domain bound to the ace2 receptor

Combining convolutional and recurrent neural networks for classification of focal liver lesions in multi-phase ct images

Development and validation of a clinical risk score to predict the occurrence of critical 445 illness in hospitalized patients with covid-19

Early triage of critically ill covid-19 patients using deep 450 learning

Deep-covid: Predicting covid-19 from chest x-ray images using deep transfer learning

Transfer learning improves supervised image segmentation across imaging protocols

Weighting training images by maximizing distribution similarity for supervised segmentation across scanners

Tadam: Task dependent adaptive metric for im-460 proved few-shot learning

Coronavirus disease 2019 (covid-19): situation report

Low-shot learning with imprinted weights

Rienstra, of angiotensin-converting enzyme 2 in men and women with heart failure and effects of reninangiotensin-aldosterone inhibitors

Grad-cam: Visual explanations from deep networks via gradient-based localization

An end-to-end trainable neural network for image-based sequence recognition and its application to scene text recognition

Attention-based vgg-16 model for covid-19 chest x-ray image 475 classification

Prototypical networks for few-shot learning

Immunological and inflammatory profiles in mild and severe cases of

Cytokine storm in covid-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Journal of the royal statistical 485 society series b-methodological 58

Domain adaptation for alzheimer's disease diagnostics

A noise-robust framework for automatic segmentation of covid-19 pneumonia lesions from 490 ct images

Frequency and distribution of chest radiographic findings

Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention

Federated semi-supervised learning for covid region segmentation in chest ct using multi-national data from china, italy, japan

Clinical course and outcomes of critically ill patients with sars-cov-2 pneumonia in wuhan, china: 505 a single-centered, retrospective, observational study

The pathogenesis and treatment of thecytokine storm'in covid-19

Liver injury in covid-19: management and challenges

Clinically applicable ai system 515 for accurate diagnosis, quantitative measurements, and prognosis of covid-19 pneumonia using computed tomography

Clinically applicable ai system for accurate diagnosis, quantitative measurements, and prognosis of covid-19 pneumonia using computed tomography

Spatio-temporal convolutional lstms for tumor growth prediction by learning 4d longitudinal patient data

Covid-19 and the cardiovascular system

Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan

Long range early diagnosis of alzheimer's disease using longitudinal mr imaging data